Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3ukl | FAD | UDP-galactopyranose mutase |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3ukl | FAD | UDP-galactopyranose mutase | / | 1.000 | |
| 3ukk | FDA | UDP-galactopyranose mutase | / | 0.609 | |
| 4u8k | FDA | UDP-galactopyranose mutase | / | 0.592 | |
| 3ukk | FAD | UDP-galactopyranose mutase | / | 0.590 | |
| 3uth | FDA | UDP-galactopyranose mutase | / | 0.581 | |
| 4u8o | FDA | UDP-galactopyranose mutase | / | 0.576 | |
| 4gde | FDA | UDP-galactopyranose mutase | / | 0.575 | |
| 3utg | FDA | UDP-galactopyranose mutase | / | 0.570 | |
| 4wx1 | FDA | UDP-galactopyranose mutase | / | 0.568 | |
| 3ukf | FDA | UDP-galactopyranose mutase | / | 0.565 | |
| 4u8m | FDA | UDP-galactopyranose mutase | / | 0.534 | |
| 3utf | FDA | UDP-galactopyranose mutase | / | 0.500 | |
| 4gdd | FAD | UDP-galactopyranose mutase | / | 0.492 | |
| 4u8l | FDA | UDP-galactopyranose mutase | / | 0.487 | |
| 4u8n | FDA | UDP-galactopyranose mutase | / | 0.485 | |
| 4gdc | FAD | UDP-galactopyranose mutase | / | 0.468 | |
| 4u8p | FDA | UDP-galactopyranose mutase | / | 0.466 | |
| 4u8j | FDA | UDP-galactopyranose mutase | / | 0.457 | |
| 5hhf | FDA | UDP-galactopyranose mutase | / | 0.443 |